Within the study period of two years, CDMS occurred in 45% of the placebo group compared to 28% of the Betaferon group (Kaplan-Meier estimates).
Kahe aasta jooksul esines CDMS- i platseeborühmas 45% võrreldes 28% Betaferon’ i rühmas (Kaplan- Meieri hinnang).